Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai, Dianbo Liu, Miao Liu, et al.
Cancer Discovery (2020) Vol. 10, Iss. 6, pp. 783-791
Open Access | Times Cited: 1542

Showing 1-25 of 1542 citing articles:

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, et al.
The Lancet (2020) Vol. 395, Iss. 10241, pp. 1907-1918
Open Access | Times Cited: 1707
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee, Jean‐Baptiste Cazier, Vasileios Angelis, et al.
The Lancet (2020) Vol. 395, Iss. 10241, pp. 1919-1926
Open Access | Times Cited: 1110
Determinants of COVID-19 disease severity in patients with cancer
Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, et al.
Nature Medicine (2020) Vol. 26, Iss. 8, pp. 1218-1223
Open Access | Times Cited: 596
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 10, pp. 1309-1316
Open Access | Times Cited: 574
COVID-19 in Immunocompromised Hosts: What We Know So Far
Monica Fung, Jennifer M. Babik
Clinical Infectious Diseases (2020) Vol. 72, Iss. 2, pp. 340-350
Open Access | Times Cited: 509
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
Adam Booth, Angus B. Reed, Sonia Ponzo, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247461-e0247461
Open Access | Times Cited: 487
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin Bange, Nicholas Han, Paul Wileyto, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1280-1289
Open Access | Times Cited: 451
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
Akshay Sharma, Neel S. Bhatt, Andrew St. Martin, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 3, pp. e185-e193
Open Access | Times Cited: 339
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (2020) Vol. 139, pp. 43-50
Open Access | Times Cited: 320
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper, et al.
Annals of Oncology (2021) Vol. 32, Iss. 6, pp. 787-800
Open Access | Times Cited: 299
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Giuseppe Curigliano, Susana Banerjee, Andrés Cervantes, et al.
Annals of Oncology (2020) Vol. 31, Iss. 10, pp. 1320-1335
Open Access | Times Cited: 289
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study
Alvina G. Lai, Laura Pasea, Amitava Banerjee, et al.
BMJ Open (2020) Vol. 10, Iss. 11, pp. e043828-e043828
Open Access | Times Cited: 279
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
Jee Myung Yang, Hyun Yong Koh, Sung Yong Moon, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 4, pp. 790-798
Open Access | Times Cited: 271
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 261
COVID-19 in patients with lung cancer
Jie Luo, Hira Rizvi, Isabel R. Preeshagul, et al.
Annals of Oncology (2020) Vol. 31, Iss. 10, pp. 1386-1396
Open Access | Times Cited: 256
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
Justin Jee, Michael B. Foote, Melissa Lumish, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 30, pp. 3538-3546
Open Access | Times Cited: 255
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, et al.
Leukemia (2020) Vol. 34, Iss. 9, pp. 2354-2363
Open Access | Times Cited: 251
Impact of COVID-19 on the thyroid gland: an update
Lorenzo Scappaticcio, Fabián Pitoia, Katherine Esposito, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 4, pp. 803-815
Open Access | Times Cited: 246
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
Jia Luo, Hira Rizvi, Jacklynn V. Egger, et al.
Cancer Discovery (2020) Vol. 10, Iss. 8, pp. 1121-1128
Open Access | Times Cited: 234
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
Lars F. Westblade, Gagandeep Brar, Laura C. Pinheiro, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 661-671.e2
Open Access | Times Cited: 231
COVID-19 in cancer patients: risk, clinical features, and management
Cuiwei Liu, Yanxia Zhao, Derick Okwan‐Duodu, et al.
Cancer Biology and Medicine (2020) Vol. 17, Iss. 3, pp. 519-527
Open Access | Times Cited: 218
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
James Glasbey, Dmitri Nepogodiev, Joana Simões, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 1, pp. 66-78
Open Access | Times Cited: 215
Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, et al.
Gut (2020) Vol. 70, Iss. 1, pp. 76-84
Closed Access | Times Cited: 214
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
Jennifer A. Belsky, Brian P. Tullius, Margaret Lamb, et al.
Journal of Infection (2021) Vol. 82, Iss. 3, pp. 329-338
Open Access | Times Cited: 212
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019
Dima Dandachi, Grant Geiger, Mary W. Montgomery, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1964-e1972
Open Access | Times Cited: 206
Page 1 - Next Page

Scroll to top